Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance.

Johnson, Kate M; Jiao, Boshen; Ramsey, Scott D; Bender, M A; Devine, Beth; Basu, Anirban

Johnson, Kate M; Jiao, Boshen; Ramsey, Scott D; Bender, M A; Devine, Beth; Basu, Anirban.

Afiliação

Johnson KM; The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute, Department of Pharmacy, University of Washington, Seattle, WA.
Jiao B; Faculty of Pharmaceutical Sciences and Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Ramsey SD; The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute, Department of Pharmacy, University of Washington, Seattle, WA.
Bender MA; The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute, Department of Pharmacy, University of Washington, Seattle, WA.
Devine B; Division of Public Health Sciences and Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA.
Basu A; Department of Pediatrics, University of Washington, Seattle, WA.

Blood Adv ; 7(3): 365-374, 2023 02 14.

Article em En | MEDLINE | ID: mdl-35575558

Assuntos

Anemia Falciforme; Seguro; Masculino; Humanos; Feminino; Adulto; Adolescente; Adulto Jovem; Estudos Retrospectivos; Custos de Cuidados de Saúde; Anemia Falciforme/epidemiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Seguro / Anemia Falciforme Tipo de estudo: Health_economic_evaluation Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google